Neurovascular Devices | Market Insights | Asia Pacific | 2019
Despite barriers to patients’ access to neurovascular treatments, particularly in the underpenetrated Chinese and Indian markets, improving healthcare infrastructure, growing demand, and clinical data supporting the endovascular approach over surgical interventions for treating neurovascular diseases will support procedure volume growth in Asia Pacific countries, resulting in strong market growth through 2027.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Neurovascular devices in Asia Pacific across a 10-year period.
